Sca International Artal Net Worth & Insider Trades
Sca International Artal - Director, Lexicon Pharmaceuticals, Inc
What is Sca International Artal's Net Worth?
The current estimated net worth of Lexicon Pharmaceuticals, Inc's Director, Sca International Artal, is estimated to be about $11B . Sca International Artal owns about 67,662,150 units of Lexicon Pharmaceuticals, Inc common stock. In the last 8 years at Lexicon Pharmaceuticals, Inc, Sca International Artal has sold an estimated value of $0 worth.
What is Sca International Artal's Past Insider Trading?
Sca International Artal's largest purchase order was 149,253,731 units , worth over $150M on November 26, 2014. In total, Sca International Artal has made about 13 transactions over 8 years of their time at Lexicon Pharmaceuticals, Inc. Sca International Artal usually trades in June, with the busiest year in 2018. The most recent transaction was a purchase order of 10,937,500 units , worth over $35M on December 17, 2020.
Artal International SCA, Amaury Wittouck, Artal International Management SA, SA Group Artal, SA Westend, Westend Administratiekantoor Stichting, Invus Public Equities LP, Invus LP, Invus Public Equities Advisors LLC, Invus Advisors LLC
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Sca International Artal's' Mailing Address?
- Mailing address is Valley Park 44, Rue de la Vallee Luxembourg N4 L-2661 Luxembourg
What are Lexicon Pharmaceuticals, Inc's Past Insider Trades?
Lexicon Pharmaceuticals, Inc's most recent insider trade came on August 9, 2022 by Invus Us Partners Llc, Ulys Llc and Raymond Debbane who bought 147,390 units worth $368.48K . In the last 15 years, insiders at Lexicon Pharmaceuticals, Inc have sold an estimated value of $4.48M and bought an estimated value of $787.45M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Raymond Debbane, Director, Jeffrey L Wade, President and CFO, and Alan J Main, EVP .
LEXICON PHARMACEUTICALS, INC. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||